Karbinalâ„¢ ER

For Symptomatic Treatment of Seasonal Allergies

Karbinal™ ER (carbinoxamine maleate) Extended-release Oral Suspension provides symptomatic relief of seasonal and perennial allergic rhinitis in children at least 2 years of age.

About Karbinal ER

Important Safety Information

Contraindications:

  • Children younger than 2 years of age.
  • Nursing mothers.
  • Patients with known hypersensitivity to the drug or any of its inactive ingredients.
  • Patients taking monoamine oxidase inhibitors (MAOI).

Warnings and Precautions:

  • Deaths have been reported in children less than 2 years of age who were taking carbinoxamine-containing drug products. Do not give Karbinal ER to children younger than 2 years of age.
  • Caution patients to avoid engaging in hazardous tasks requiring mental alertness and motor coordination, such as driving or operating machinery.
  • Use with caution in patients with increased intraocular pressure, narrow angle glaucoma, hyperthyroidism, cardiovascular disease, hypertension, stenosing peptic ulcer, symptomatic prostatic hypertrophy, bladder neck obstruction, or pyloroduodenal obstruction.
  • Karbinal ER contains sodium metabisulfite, a sulfite which may cause anaphylaxis and life-threatening or less severe asthmatic episodes in susceptible individuals.

Important Safety Information

  • Deaths have been reported in children less than 2 years of age who were taking carbinoxamine-containing drug products. Do not give Karbinal ER to children younger than 2 years of age.
  • Caution patients to avoid engaging in hazardous tasks requiring mental alertness and motor coordination, such as driving or operating machinery.
  • Use with caution in patients with increased intraocular pressure, narrow angle glaucoma, hyperthyroidism, cardiovascular disease, hypertension, stenosing peptic ulcer, symptomatic prostatic hypertrophy, bladder neck obstruction, or pyloroduodenal obstruction.
  • Karbinal ER contains sodium metabisulfite, a sulfite which may cause anaphylaxis and life-threatening or less severe asthmatic episodes in susceptible individuals.
See additional important safety information